DIFFUSIO2N
Dead / Abandoned — Abandoned — no statement of use filed (as of 21 Sept 2026)
What this means for you
This application is over — abandoned 21 Sept 2026. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97508583
- Mark type
- Stylized text
- Filed
- 18 Jul 2022
- Published for opposition
- 19 Dec 2023
- Abandoned
- 21 Sept 2026
- Attorney of record
- Marya K. Jones
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals, namely, drugs that increase tissue oxygenation, drugs that assist with cancer treatment, drugs that increase tissue oxygenation that enhance performance of mammals
Owner
- Diffusion Pharmaceuticals LLC, Charlottesville, VA, US
- Diffusion Pharmaceuticals LLC, Charlottesville, VA, US
Prosecution history
- 21 Sept 2026 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 21 Sept 2026 — ABANDONMENT - NO USE STATEMENT FILED
- 21 Sept 2026 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 21 Sept 2026 — ABANDONMENT - NO USE STATEMENT FILED
- 09 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Mar 2026 — SOU EXTENSION 4 GRANTED
- 13 Feb 2026 — SOU EXTENSION 4 FILED
- 09 Mar 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 17 Feb 2026 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 17 Feb 2026 — NOTICE OF REVIVAL - E-MAILED
- 17 Feb 2026 — PETITION TO REVIVE-GRANTED
- 17 Feb 2026 — TEAS PETITION TO REVIVE RECEIVED
- 13 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Aug 2025 — SOU EXTENSION 3 GRANTED
- 12 Aug 2025 — SOU EXTENSION 3 FILED